GLYXAMBI is a once a day pill for adults with T2D who may benefit from additional glycemic control. See Important Safety Information, PI, and Med Guide.
of GLYXAMBI Significantly reduce A1C for patients who are inadequately controlled on metformin* The #1 prescribed SGLT2i, Jardiance® (empagliflozin) tablets†combined with the only single-strength DPP-4i, Tradjenta® (linagliptin) tablets in 1 co-pay ...
With diet and exercise, GLYXAMBI lowers A1C in adults with type 2 diabetes. Learn how it works and about its side effects. View ISI, PI and Med Guide.
Applies to: enalapril and Glyxambi (empagliflozin / linagliptin) Using linagliptin together with enalapril may cause angioedema, a condition associated with swelling of the face, eyes, lips, tongue, throat, and occasionally also the hands and feet. Each medication alone can also cause angioedema, bu...
Applies to: bexarotene and Glyxambi (empagliflozin / linagliptin) Using bexarotene together with linagliptin may increase the risk of pancreatitis, or inflammation of the pancreas. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do ...
Glyxambi works in a few ways to help keep your blood sugar levels from getting too high. It increases the levels of natural hormones in your body to help lower blood sugar by increasing insulin levels, especially after meals. It decreases the amount of sugar that is made by the liver. Gly...
Glyxambi works in a few ways to help keep your blood sugar levels from getting too high. It increases the levels of natural hormones in your body to help lower blood sugar by increasing insulin levels, especially after meals. It decreases the amount of sugar that is made by the liver. Gly...
2015年2月,美国FDA批准新型复方降糖药物Glyxambi(恩格列净/利格列汀)的上市申请,用于2型糖尿病成年患者的辅助治疗。 Glyxambi是一天一次的口服片剂(用法是早晨服用,每日一次)。有10mg恩格列净/5mg利格列汀和25mg恩格列净/5mg利格列汀两种剂型。 该药也是目前美国唯一的一款SGLT2抑制剂(恩格列净[empagliflozin],勃林...
Glyxambi购买咨询 QQ2645497356 英文名: Empagliflozin And Linagliptin Tablets 规格: 10mg/5mg(恩格列净/利格列汀) 持证商: Boehringer Ingelheim International Gmbh 上市国家: 欧盟上市 参比制剂目录: 49-15 征求意见稿买参比制剂 找麦冬生物QQ2645497356
Glyxambi是恩格列净(empagliflozin,勃林格殷格翰)和利格列汀(linagliptin,礼来)的复方药物。Glyxambi不适用于1型糖尿病或糖尿病酮症酸中毒的治疗。该药已于2015年获FDA批准用于相同适应症。 Empagliflozin属于钠-葡萄糖协同转运蛋白-2(SGLT-2)抑制剂类药物,主要...